Stock Information
Gilead Sciences Inc (GILD)
Ticker Symbol: GILD
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $165,754.47 mil
Piotroski score: 6
PE Ratio: 18.0127
EPS (TTM): 7.3515
Revenue (TTM): $23.71 M
Dividend Yield: 2.4078696226692%
ROE: 42.21%
Latest News
-
Three Stocks That May Be Trading Below Estimated Value In May 2026
Fri, May 29, 2026 5:38 PM
-
Discover May 2026's Stocks That Could Be Trading Below Estimated Value
Fri, May 29, 2026 11:37 AM
-
Atea Pharmaceuticals: I'm Optimistic Ahead Of Critical HPV Catalyst
Fri, May 29, 2026 11:19 AM
-
Gilead Sciences, Inc. (GILD) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript
Fri, May 29, 2026 10:54 AM
-
Allogene CEO to step down; Agios drug fails key test
Fri, May 29, 2026 10:17 AM
-
Gilead (GILD) Wins FDA Approval for First HDV Treatment Hepcludex
Fri, May 29, 2026 6:04 AM
-
S&P 500, Nasdaq Rise to Another Record. Software Strikes Back.
Thu, May 28, 2026 8:01 PM
-
Novel Spanish, Culturally Adapted Metastatic Breast Cancer Symptom Management Guide Debuts at ASCO 2026
Thu, May 28, 2026 11:05 AM
-
FDA accelerated approval of Hepcludex significant milestone for US HDV market
Thu, May 28, 2026 10:47 AM
-
Building A $100,000 All-Weather Dividend Portfolio For May 2026
Thu, May 28, 2026 9:00 AM
Key Financials
Financial data not available
